"Southeast BIO (SEBIO)'s mission is to foster the growth of the life sciences industry in the Southeastern United States by promoting entrepreneurship and bringing together the key stakeholders active in the development of the industry."

Tellus Therapeutics wins Early Stage Company Shootout

Tellus Therapeutics wins Early Stage Company Shootout

An A-list group of investors and companies attended the 20th Anniversary Southeast BIO Investor & Partnering Forum (SEBIO) on November 13-14th at the Loews Hotel in Atlanta. The Forum is the Southeast’s only regional life sciences venture capital conference. As always, one of the most popular parts of the conference is the Early Stage Shootout.

read more

SEBIO Recap of the 20th Anniversary Forum

SEBIO Recap of the 20th Anniversary Forum

An A-list group of investors and companies attended the 20th Anniversary Southeast BIO Investor & Partnering Forum (SEBIO) on November 13-14th at the Loews Hotel in Atlanta. The Forum is the Southeast’s only regional life sciences venture capital conference.

“The success of this year’s Forum is a testament to SEBIO’s significant role in connecting investment capital from up and down the eastern U.S. with the most promising biomedical companies for our seven-state region,” said Todd Sherer, Chair of SEBIO and Emory University Interim Vice President of Research. “The conference was as exciting as it has ever been.  As a networking event, the quality and high level of attendees produced a tremendous intensity of networking.”

read more

Generex Biotechnology Expands Medical Device Portfolio With Acquisition of Olaregen Therapeutix Inc.

Generex Biotechnology Expands Medical Device Portfolio With Acquisition of Olaregen Therapeutix Inc.

Generex Biotechnology Corporation (OTC:GNBT) announced today the signing of a Letter of Intent to acquire 51 percent of Olaregen Therapeutix Inc., a New York-based regenerative medicine company.

read more